logo
episode-header-image
Nov 2024
18m 22s

CAR T Cells and T-Cell Therapies for Can...

JAMA NETWORK
About this episode

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss "CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review."

Related Content:

Up next
Nov 17
Diagnosis and Treatment of Peripheral Neuropathy
<p>Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss diagnosis and optimal management of p ... Show More
22 m
Nov 10
Diagnosis and Treatment of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers. Author Norbert Stefan, MD, from the University ... Show More
26m 21s
Nov 3
Moving Toward a Safer World by 2040
The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of Washington joins JAMA Editor in Chief Kirsten ... Show More
15m 54s
Recommended Episodes
May 2021
Ep. 4: “Therapeutic T Cell Engineering” Featuring Drs. Carl June and Philipp Rommel
Dr. Carl June is the Richard W. Vague Professor in Immunology at the University of Pennsylvania, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, and Director of the Parker Institute for Cancer Immunotherapy. Dr. Philipp Rommel is a Postdoct ... Show More
1h 13m
Mar 2021
Ep. 1: “Merging Stem Cells with Immunology” Featuring Dr. Filipe Pereira
Dr. Filipe Pereira is an Associate Professor at the Lund Stem Cell Center at Lund University. The Pereira lab studies how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired by the fields of stem cell biology, immunology, and cancer, th ... Show More
58m 58s
Apr 2021
Ep. 2: “A Tale of Three Sisters” Featuring Drs. Mindy, Amy, and Kristen Engevik
Drs. Mindy, Amy, and Kristen Engevik are sisters and immunologists. Mindy and Amy are Assistant Professors at the Medical University of South Carolina and Kristen is a Postdoctoral Fellow at Baylor College of Medicine. 
1h 13m
Dec 2024
Science’s Breakthrough of the Year, and psychedelic drugs, climate, and fusion technology updates
First up this week, Breakthroughs Editor Greg Miller joins producer Meagan Cantwell to discuss Science’s 2024 Breakthrough of the Year. They also discuss some of the other scientific achievements that turned heads this year, from ancient DNA and autoimmune therapy, to precision p ... Show More
44m 46s
Jul 2019
Why Dogs Now Play a Big Role in Human Cancer Research
The Cancer Moonshot initiative, launched under the Obama administration, was audacious by design: Supercharge cancer research to encourage innovation, with the mission “to end to cancer as we know it.” Cancer researchers avoid using the word “cure.” From studying cancer at the mo ... Show More
7m 10s
Nov 2024
Cancer Cells Gone Wild: Real Biology Exposed
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman discuss the complexities of cancer with Dr. Joe Zundell, a cancer biologist. They explore the definition of cancer, its prevalence, and the hallmarks that characterize cancer cells. The conversation delves into the mecha ... Show More
59m 38s
Jun 2023
Unleashing CRISPR on Cancer
In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ... Show More
52m 50s
Aug 14
11: Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma
The latest Oncology Decoded discussion with Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute (SCRI) and medical oncologist with Rocky Mountain Cancer Centers specializing in solid tumors and ... Show More
41m 45s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Listen to millions of songs and podcasts on Anghami